Report ID : AMR1003934 | Industries : Others | Published On :December 2023 | Page Count : 212
Global Antacids Market
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Antacids Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to Recent Energy Crisis
4.2.5 Cumulative Impact due to Nearing Economic Downturn
4.2.6 Post Covid-19 World Supply & Demand Conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Antacids Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global Antacids Market Share Analysis, By Type
5.3 Global Antacids Market Size and Forecast, By Type
5.3.1 Sodium Antacids
5.3.2 Calcium Antacids
5.3.3 Magnesium Antacids
5.3.4 Aluminium Antacids
5.3.5 Others
6 Global Antacids Market, By Indication
6.1 Y-o-Y Growth Comparison, By Indication
6.2 Global Antacids Market Share Analysis, By Indication
6.3 Global Antacids Market Size and Forecast, By Indication
6.3.1 Gastroesophageal Reflux Disease
6.3.2 Heartburn
6.3.3 indigestion
6.3.4 Others
7 Global Antacids Market, By Dosage Form
7.1 Y-o-Y Growth Comparison, By Dosage Form
7.2 Global Antacids Market Share Analysis, By Dosage Form
7.3 Global Antacids Market Size and Forecast, By Dosage Form
7.3.1 Tablets
7.3.2 Liquid
7.3.3 Others
8 Global Antacids Market, By Route of Administration
8.1 Y-o-Y Growth Comparison, By Route of Administration
8.2 Global Antacids Market Share Analysis, By Route of Administration
8.3 Global Antacids Market Size and Forecast, By Route of Administration
8.3.1 Oral
8.3.2 Others
9 Global Antacids Market, By Distribution Channel
9.1 Y-o-Y Growth Comparison, By Distribution Channel
9.2 Global Antacids Market Share Analysis, By Distribution Channel
9.3 Global Antacids Market Size and Forecast, By Distribution Channel
9.3.1 Hospital Pharmacy
9.3.2 Online Pharmacy
9.3.3 Retail Pharmacy
10 Global Antacids Market, By End-users
10.1 Y-o-Y Growth Comparison, By End-users
10.2 Global Antacids Market Share Analysis, By End-users
10.3 Global Antacids Market Size and Forecast, By End-users
10.3.1 Hospitals
10.3.2 Homecare
10.3.3 Speciality Centres
10.3.4 Others
11 Global Antacids Market, By Region
11.1 Global Antacids Market Share Analysis, By Region
11.2 Global Antacids Market Size and Forecast, By Region
11.3 Global Antacids Market Trends and Forecast, By Region
12 North America Antacids Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 North America Antacids Market Size and Forecast, By Type
12.3 North America Antacids Market Size and Forecast, By Indication
12.4 North America Antacids Market Size and Forecast, By Dosage Form
12.5 North America Antacids Market Size and Forecast, By Route of Administration
12.6 North America Antacids Market Size and Forecast, By Distribution Channel
12.7 North America Antacids Market Size and Forecast, By End-users
12.8 North America Antacids Market Size and Forecast, By Country
12.8.1 U.S.
12.8.1.1 Market Size and Forecast, By Type
12.8.1.2 Market Size and Forecast, By Indication
12.8.1.3 Market Size and Forecast, By Dosage Form
12.8.1.4 Market Size and Forecast, By Route of Administration
12.8.1.5 Market Size and Forecast, By Distribution Channel
12.8.1.6 Market Size and Forecast, By End-users
12.8.2 Canada
12.8.2.1 Market Size and Forecast, By Type
12.8.2.2 Market Size and Forecast, By Indication
12.8.2.3 Market Size and Forecast, By Dosage Form
12.8.2.4 Market Size and Forecast, By Route of Administration
12.8.2.5 Market Size and Forecast, By Distribution Channel
12.8.2.6 Market Size and Forecast, By End-users
12.8.3 Mexico
12.8.3.1 Market Size and Forecast, By Type
12.8.3.2 Market Size and Forecast, By Indication
12.8.3.3 Market Size and Forecast, By Dosage Form
12.8.3.4 Market Size and Forecast, By Route of Administration
12.8.3.5 Market Size and Forecast, By Distribution Channel
12.8.3.6 Market Size and Forecast, By End-users
13 Europe Antacids Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Europe Antacids Market Size and Forecast, By Type
13.3 Europe Antacids Market Size and Forecast, By Indication
13.4 Europe Antacids Market Size and Forecast, By Dosage Form
13.5 Europe Antacids Market Size and Forecast, By Route of Administration
13.6 Europe Antacids Market Size and Forecast, By Distribution Channel
13.7 Europe Antacids Market Size and Forecast, By End-users
13.8 Europe Antacids Market Size and Forecast, By Country
13.8.1 Germany
13.8.1.1 Market Size and Forecast, By Type
13.8.1.2 Market Size and Forecast, By Indication
13.8.1.3 Market Size and Forecast, By Dosage Form
13.8.1.4 Market Size and Forecast, By Route of Administration
13.8.1.5 Market Size and Forecast, By Distribution Channel
13.8.1.6 Market Size and Forecast, By End-users
13.8.2 France
13.8.2.1 Market Size and Forecast, By Type
13.8.2.2 Market Size and Forecast, By Indication
13.8.2.3 Market Size and Forecast, By Dosage Form
13.8.2.4 Market Size and Forecast, By Route of Administration
13.8.2.5 Market Size and Forecast, By Distribution Channel
13.8.2.6 Market Size and Forecast, By End-users
13.8.3 UK
13.8.3.1 Market Size and Forecast, By Type
13.8.3.2 Market Size and Forecast, By Indication
13.8.3.3 Market Size and Forecast, By Dosage Form
13.8.3.4 Market Size and Forecast, By Route of Administration
13.8.3.5 Market Size and Forecast, By Distribution Channel
13.8.3.6 Market Size and Forecast, By End-users
13.8.4 Russia
13.8.4.1 Market Size and Forecast, By Type
13.8.4.2 Market Size and Forecast, By Indication
13.8.4.3 Market Size and Forecast, By Dosage Form
13.8.4.4 Market Size and Forecast, By Route of Administration
13.8.4.5 Market Size and Forecast, By Distribution Channel
13.8.4.6 Market Size and Forecast, By End-users
13.8.5 Italy
13.8.5.1 Market Size and Forecast, By Type
13.8.5.2 Market Size and Forecast, By Indication
13.8.5.3 Market Size and Forecast, By Dosage Form
13.8.5.4 Market Size and Forecast, By Route of Administration
13.8.5.5 Market Size and Forecast, By Distribution Channel
13.8.5.6 Market Size and Forecast, By End-users
13.8.6 Spain
13.8.6.1 Market Size and Forecast, By Type
13.8.6.2 Market Size and Forecast, By Indication
13.8.6.3 Market Size and Forecast, By Dosage Form
13.8.6.4 Market Size and Forecast, By Route of Administration
13.8.6.5 Market Size and Forecast, By Distribution Channel
13.8.6.6 Market Size and Forecast, By End-users
13.8.7 Rest of Europe
13.8.7.1 Market Size and Forecast, By Type
13.8.7.2 Market Size and Forecast, By Indication
13.8.7.3 Market Size and Forecast, By Dosage Form
13.8.7.4 Market Size and Forecast, By Route of Administration
13.8.7.5 Market Size and Forecast, By Distribution Channel
13.8.7.6 Market Size and Forecast, By End-users
14 Asia Pacific Antacids Market Analysis and Forecast (2023-2030)
14.1 Introduction
14.2 Asia Pacific Antacids Market Size and Forecast, By Type
14.3 Asia Pacific Antacids Market Size and Forecast, By Indication
14.4 Asia Pacific Antacids Market Size and Forecast, By Dosage Form
14.5 Asia Pacific Antacids Market Size and Forecast, By Route of Administration
14.6 Asia Pacific Antacids Market Size and Forecast, By Distribution Channel
14.7 Asia Pacific Antacids Market Size and Forecast, By End-users
14.8 Asia Pacific Antacids Market Size and Forecast, By Country
14.8.1 China
14.8.1.1 Market Size and Forecast, By Type
14.8.1.2 Market Size and Forecast, By Indication
14.8.1.3 Market Size and Forecast, By Dosage Form
14.8.1.4 Market Size and Forecast, By Route of Administration
14.8.1.5 Market Size and Forecast, By Distribution Channel
14.8.1.6 Market Size and Forecast, By End-users
14.8.2 Japan
14.8.2.1 Market Size and Forecast, By Type
14.8.2.2 Market Size and Forecast, By Indication
14.8.2.3 Market Size and Forecast, By Dosage Form
14.8.2.4 Market Size and Forecast, By Route of Administration
14.8.2.5 Market Size and Forecast, By Distribution Channel
14.8.2.6 Market Size and Forecast, By End-users
14.8.3 India
14.8.3.1 Market Size and Forecast, By Type
14.8.3.2 Market Size and Forecast, By Indication
14.8.3.3 Market Size and Forecast, By Dosage Form
14.8.3.4 Market Size and Forecast, By Route of Administration
14.8.3.5 Market Size and Forecast, By Distribution Channel
14.8.3.6 Market Size and Forecast, By End-users
14.8.4 South Korea
14.8.4.1 Market Size and Forecast, By Type
14.8.4.2 Market Size and Forecast, By Indication
14.8.4.3 Market Size and Forecast, By Dosage Form
14.8.4.4 Market Size and Forecast, By Route of Administration
14.8.4.5 Market Size and Forecast, By Distribution Channel
14.8.4.6 Market Size and Forecast, By End-users
14.8.5 Australia
14.8.5.1 Market Size and Forecast, By Type
14.8.5.2 Market Size and Forecast, By Indication
14.8.5.3 Market Size and Forecast, By Dosage Form
14.8.5.4 Market Size and Forecast, By Route of Administration
14.8.5.5 Market Size and Forecast, By Distribution Channel
14.8.5.6 Market Size and Forecast, By End-users
14.8.6 New Zealand
14.8.6.1 Market Size and Forecast, By Type
14.8.6.2 Market Size and Forecast, By Indication
14.8.6.3 Market Size and Forecast, By Dosage Form
14.8.6.4 Market Size and Forecast, By Route of Administration
14.8.6.5 Market Size and Forecast, By Distribution Channel
14.8.6.6 Market Size and Forecast, By End-users
14.8.7 Singapore
14.8.7.1 Market Size and Forecast, By Type
14.8.7.2 Market Size and Forecast, By Indication
14.8.7.3 Market Size and Forecast, By Dosage Form
14.8.7.4 Market Size and Forecast, By Route of Administration
14.8.7.5 Market Size and Forecast, By Distribution Channel
14.8.7.6 Market Size and Forecast, By End-users
14.8.8 Malaysia
14.8.8.1 Market Size and Forecast, By Type
14.8.8.2 Market Size and Forecast, By Indication
14.8.8.3 Market Size and Forecast, By Dosage Form
14.8.8.4 Market Size and Forecast, By Route of Administration
14.8.8.5 Market Size and Forecast, By Distribution Channel
14.8.8.6 Market Size and Forecast, By End-users
14.8.9 Rest of Asia
14.8.9.1 Market Size and Forecast, By Type
14.8.9.2 Market Size and Forecast, By Indication
14.8.9.3 Market Size and Forecast, By Dosage Form
14.8.9.4 Market Size and Forecast, By Route of Administration
14.8.9.5 Market Size and Forecast, By Distribution Channel
14.8.9.6 Market Size and Forecast, By End-users
15 Latin America Antacids Market Analysis and Forecast (2023-2030)
15.1 Introduction
15.2 Latin America Antacids Market Size and Forecast, By Type
15.3 Latin America Antacids Market Size and Forecast, By Indication
15.4 Latin America Antacids Market Size and Forecast, By Dosage Form
15.5 Latin America Antacids Market Size and Forecast, By Route of Administration
15.6 Latin America Antacids Market Size and Forecast, By Distribution Channel
15.7 Latin America Antacids Market Size and Forecast, By End-users
15.8 Latin America Antacids Market Size and Forecast, By Country
15.8.1 Brazil
15.8.1.1 Market Size and Forecast, By Type
15.8.1.2 Market Size and Forecast, By Indication
15.8.1.3 Market Size and Forecast, By Dosage Form
15.8.1.4 Market Size and Forecast, By Route of Administration
15.8.1.5 Market Size and Forecast, By Distribution Channel
15.8.1.6 Market Size and Forecast, By End-users
15.8.2 Argentina
15.8.2.1 Market Size and Forecast, By Type
15.8.2.2 Market Size and Forecast, By Indication
15.8.2.3 Market Size and Forecast, By Dosage Form
15.8.2.4 Market Size and Forecast, By Route of Administration
15.8.2.5 Market Size and Forecast, By Distribution Channel
15.8.2.6 Market Size and Forecast, By End-users
15.8.3 Colombia
15.8.3.1 Market Size and Forecast, By Type
15.8.3.2 Market Size and Forecast, By Indication
15.8.3.3 Market Size and Forecast, By Dosage Form
15.8.3.4 Market Size and Forecast, By Route of Administration
15.8.3.5 Market Size and Forecast, By Distribution Channel
15.8.3.6 Market Size and Forecast, By End-users
15.8.4 Peru
15.8.4.1 Market Size and Forecast, By Type
15.8.4.2 Market Size and Forecast, By Indication
15.8.4.3 Market Size and Forecast, By Dosage Form
15.8.4.4 Market Size and Forecast, By Route of Administration
15.8.4.5 Market Size and Forecast, By Distribution Channel
15.8.4.6 Market Size and Forecast, By End-users
15.8.5 Chile
15.8.5.1 Market Size and Forecast, By Type
15.8.5.2 Market Size and Forecast, By Indication
15.8.5.3 Market Size and Forecast, By Dosage Form
15.8.5.4 Market Size and Forecast, By Route of Administration
15.8.5.5 Market Size and Forecast, By Distribution Channel
15.8.5.6 Market Size and Forecast, By End-users
15.8.6 Venezuela
15.8.6.1 Market Size and Forecast, By Type
15.8.6.2 Market Size and Forecast, By Indication
15.8.6.3 Market Size and Forecast, By Dosage Form
15.8.6.4 Market Size and Forecast, By Route of Administration
15.8.6.5 Market Size and Forecast, By Distribution Channel
15.8.6.6 Market Size and Forecast, By End-users
15.8.7 Rest of Latin America
15.8.7.1 Market Size and Forecast, By Type
15.8.7.2 Market Size and Forecast, By Indication
15.8.7.3 Market Size and Forecast, By Dosage Form
15.8.7.4 Market Size and Forecast, By Route of Administration
15.8.7.5 Market Size and Forecast, By Distribution Channel
15.8.7.6 Market Size and Forecast, By End-users
16 Middle East Antacids Market Analysis and Forecast (2023-2030)
16.1 Introduction
16.2 Middle East Antacids Market Size and Forecast, By Type
16.3 Middle East Antacids Market Size and Forecast, By Indication
16.4 Middle East Antacids Market Size and Forecast, By Dosage Form
16.5 Middle East Antacids Market Size and Forecast, By Route of Administration
16.6 Middle East Antacids Market Size and Forecast, By Distribution Channel
16.7 Middle East Antacids Market Size and Forecast, By End-users
16.8 Middle East Antacids Market Size and Forecast, By Country
16.8.1 Saudi Arabia
16.8.1.1 Market Size and Forecast, By Type
16.8.1.2 Market Size and Forecast, By Indication
16.8.1.3 Market Size and Forecast, By Dosage Form
16.8.1.4 Market Size and Forecast, By Route of Administration
16.8.1.5 Market Size and Forecast, By Distribution Channel
16.8.1.6 Market Size and Forecast, By End-users
16.8.2 UAE
16.8.2.1 Market Size and Forecast, By Type
16.8.2.2 Market Size and Forecast, By Indication
16.8.2.3 Market Size and Forecast, By Dosage Form
16.8.2.4 Market Size and Forecast, By Route of Administration
16.8.2.5 Market Size and Forecast, By Distribution Channel
16.8.2.6 Market Size and Forecast, By End-users
16.8.3 Egypt
16.8.3.1 Market Size and Forecast, By Type
16.8.3.2 Market Size and Forecast, By Indication
16.8.3.3 Market Size and Forecast, By Dosage Form
16.8.3.4 Market Size and Forecast, By Route of Administration
16.8.3.5 Market Size and Forecast, By Distribution Channel
16.8.3.6 Market Size and Forecast, By End-users
16.8.4 Kuwait
16.8.4.1 Market Size and Forecast, By Type
16.8.4.2 Market Size and Forecast, By Indication
16.8.4.3 Market Size and Forecast, By Dosage Form
16.8.4.4 Market Size and Forecast, By Route of Administration
16.8.4.5 Market Size and Forecast, By Distribution Channel
16.8.4.6 Market Size and Forecast, By End-users
16.8.5 South Africa
16.8.5.1 Market Size and Forecast, By Type
16.8.5.2 Market Size and Forecast, By Indication
16.8.5.3 Market Size and Forecast, By Dosage Form
16.8.5.4 Market Size and Forecast, By Route of Administration
16.8.5.5 Market Size and Forecast, By Distribution Channel
16.8.5.6 Market Size and Forecast, By End-users
16.8.6 Rest of Middle East & Africa
16.8.6.1 Market Size and Forecast, By Type
16.8.6.2 Market Size and Forecast, By Indication
16.8.6.3 Market Size and Forecast, By Dosage Form
16.8.6.4 Market Size and Forecast, By Route of Administration
16.8.6.5 Market Size and Forecast, By Distribution Channel
16.8.6.6 Market Size and Forecast, By End-users
17 Competitive Analysis
17.1 Competition Dashboard
17.2 Market share Analysis of Top Vendors
17.3 Key Development Strategies
18 Company Profiles
18.1 Sun Pharmaceutical Industries Ltd (India)
18.1.2 Offerings
18.1.3 Key Financials
18.1.4 Business Segment & Geographic Overview
18.1.5 Key Market Developments
18.1.6 Key Strategies
18.2 Bayer AG (Germany)
18.2.1 Overview
18.2.2 Offerings
18.2.3 Key Financials
18.2.4 Business Segment & Geographic Overview
18.2.5 Key Market Developments
18.2.6 Key Strategies
18.3 Lupin (India)
18.3.1 Overview
18.3.2 Offerings
18.3.3 Key Financials
18.3.4 Business Segment & Geographic Overview
18.3.5 Key Market Developments
18.3.6 Key Strategies
18.4 Pfizer Inc (U.S.)
18.4.1 Overview
18.4.1 Overview
18.4.2 Offerings
18.4.3 Key Financials
18.4.4 Business Segment & Geographic Overview
18.4.5 Key Market Developments
18.4.6 Key Strategies
18.5 GSK Plc. (U.K.)
18.5.1 Overview
18.5.2 Offerings
18.5.3 Key Financials
18.5.4 Business Segment & Geographic Overview
18.5.5 Key Market Developments
18.5.6 Key Strategies
18.6 Bristol Myers Squibb Company (U.S.)
18.6.1 Overview
18.6.2 Offerings
18.6.3 Key Financials
18.6.4 Business Segment & Geographic Overview
18.6.5 Key Market Developments
18.6.6 Key Strategies
18.7 Teva Pharmaceutical Industries Ltd. (Israel)
18.7.1 Overview
18.7.2 Offerings
18.7.3 Key Financials
18.7.4 Business Segment & Geographic Overview
18.7.5 Key Market Developments
18.7.6 Key Strategies
18.8 Novartis AG (Switzerland)
18.8.1 Overview
18.8.2 Offerings
18.8.3 Key Financials
18.8.4 Business Segment & Geographic Overview
18.8.5 Key Market Developments
18.8.6 Key Strategies
18.9 F. Hoffmann-La Roche Ltd (Switzerland)
18.9.1 Overview
18.9.2 Offerings
18.9.3 Key Financials
18.9.4 Business Segment & Geographic Overview
18.9.5 Key Market Developments
18.9.6 Key Strategies
18.10 Hikma Pharmaceuticals PLC (Japan)
18.10.1 Overview
18.10.2 Offerings
18.10.3 Key Financials
18.10.4 Business Segment & Geographic Overview
18.10.5 Key Market Developments
18.10.6 Key Strategies
18.11 Fresenius Kabi AG (Germany)
18.11.1 Overview
18.11.2 Offerings
18.11.3 Key Financials
18.11.4 Business Segment & Geographic Overview
18.11.5 Key Market Developments
18.11.6 Key Strategies
Inquire Before Buying Request Free Sample Ask For Discount